Epizyme (NASDAQ:EPZM)

CAPS Rating: 3 out of 5

Recs

0
Player Avatar ptanabe (53.61) Submitted: 7/16/2013 7:37:51 PM : Outperform Start Price: $23.50 EPZM Score: +65.53

Eisai , Glaxo Smith Kline, Roche, Abbott, and Celgene are all working with Epizyme. They understand the science way better than I do and they partnered with them. If the science turns out to be fruitful, they will probably be the leader in epigenetics.

Featured Broker Partners


Advertisement